Asperger syndrome other diagnostic studies: Difference between revisions
| Line 5: | Line 5: | ||
<br /> | <br /> | ||
==Overview== | ==Overview== | ||
Routine neuroimaging, Electroencephalography (EEG) and | Routine [[neuroimaging]], [[Electroencephalography|electroencephalography (EEG)]] and [[Genetics|genetic]] testing are not recommended in patients with Asperger Syndrome (AS). | ||
== Neuroimaging == | == Neuroimaging == | ||
Revision as of 12:31, 20 June 2020
|
Asperger Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asperger syndrome other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Asperger syndrome other diagnostic studies |
|
Risk calculators and risk factors for Asperger syndrome other diagnostic studies |
Overview
Routine neuroimaging, electroencephalography (EEG) and genetic testing are not recommended in patients with Asperger Syndrome (AS).
Neuroimaging
Routine clinical neuroimaging such as CT, MRI, single-photon emission CT (SPECT), or positron emission tomography (PET) are not recommended in patients with autism spectrum disorders (ASD).[1][2]
Electroencephalography (EEG)
Routine electroencephalography (EEG) is not recommended in all patients with ASD and is recommended if there is a history of seizures or a history of regression.[2]
Genetic testing
Genetic testing is not routinely indicated in patients with ASD.[2]
References
- ↑ Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities (2007). "Identification and evaluation of children with autism spectrum disorders". Pediatrics. 120 (5): 1183–215. doi:10.1542/peds.2007-2361. PMID 17967920.
- ↑ 2.0 2.1 2.2 Filipek PA, Accardo PJ, Ashwal S, Baranek GT, Cook EH, Dawson G; et al. (2000). "Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society". Neurology. 55 (4): 468–79. doi:10.1212/wnl.55.4.468. PMID 10953176.